Ergoteles’s Celcuity CELC Stock Holding History

Ergoteles’s Portfolio CELC Stock Details CELC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-46,954	Closed	-$427K	–	1589
2022 Q2	$427K	Buy	+46,954	New	+$344K	0.01%	907

Other funds holding CELC

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

CAPTRUST Financial Advisors Raleigh, North Carolina $65.5B AUM 24.25% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

JAMONY

Jacob Asset Management of New York Hermosa Beach, California $70.9M AUM 14.28% 1-Year Est. Return

Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ergoteles's CELC Position: Q3 2022 in Review

Ergoteles sold out of Celcuity (CELC) in Q3 2022, closing a stake of 46,954 shares — an estimated $427K sold.

Ergoteles first reported a position in CELC in Q2 2022 and held it in 1 quarter. The position peaked at $427K in Q2 2022. 30 funds tracked by Wall St. Rank hold CELC as of Q3 2022.

Ergoteles reported no remaining Celcuity position as of Q3 2022 after selling out during the quarter.
Ergoteles sold 46,954 Celcuity shares in Q3 2022, an estimated $427K.
Ergoteles first reported a position in Celcuity in Q2 2022 and held it in 1 quarter.
Ergoteles's Celcuity position peaked at $427K in Q2 2022.
30 funds tracked by Wall St. Rank held Celcuity as of Q3 2022.

Based on Ergoteles's 13F filing for Q3 2022, filed 14 Nov 2022.